X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Examining the truth behind clinical trial costs

By John Corea  |    October 2, 2018
Last week, a study appearing in the Journal of the American Medical Association (JAMA) Internal Medicine, evaluated the costs specifically associated with successful clinical trials for novel...   Read More

New report details the setbacks and challenges to Alzheimer’s research

By Gretta Stone  |    September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...   Read More

Clinical Trials Awareness Week: Celebrating the impact of clinical research

By Andrew Powaleny  |    May 1, 2017
Today starts off the beginning of Clinical Trials Awareness Week, which shines a spotlight on how the clinical trials process helps deliver safe, effective medicines to patients.   Read More

Driving innovation through collaboration

By Emma Van Hook  |    April 17, 2017
A new report from Deloitte examines the changing landscape of biopharmaceutical research, as stakeholders across the R&D ecosystem are increasingly coming together to tackle sciences’ most vexing...   Read More

Guest Post: New threats could fundamentally alter innovation in drug manufacturing

By Guest Contributor  |    August 2, 2016
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

America’s biopharmaceutical industry is central to diverse R&D ecosystem

By Andrew Powaleny  |    March 29, 2016
America’s biopharmaceutical companies are at the heart of a robust research and development (R&D) ecosystem that supports continued medical advances for patients. This includes small and large...   Read More

Week in Review: The latest from PhRMA

By Priscilla VanderVeer  |    March 18, 2016
ICYMI: Policy solutions for innovative treatment: Last week at our 2016 Annual Meeting, our president and CEO Steve Ubl discussed his vision for the organization and outlined policy solutions for...   Read More

New Video: Clinical trials serve as engine for local economic growth

By Priscilla VanderVeer  |    November 18, 2015
Without clinical trials, new medicines could not be approved and made available to the patients who need them. But beyond connecting patients to new treatments and potential cures for some of the...   Read More

New Report: Innovation in the Biopharmaceutical R&D Process – Adapting to a Changing Environment

By Anne McDonald Pritchett, PhD  |    June 30, 2015
With the average cost of developing, testing and receiving approval for a new medicine at $2.6 billion and rising, biopharmaceutical companies are continuously looking at new ways to increase...   Read More

Collaboration for Cures: Teaming Up to Advance Science and Save Lives

By Tina Stow  |    March 26, 2015
“Whether it’s our family, our friends, all of us are potentially patients one day.” In a single sentence, Dr. Anthony Coyle, senior vice president and chief scientific officer at Pfizer’s Centers...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates